Insilico Medicine Unveils ISM0676: A Potential Game-Changer for Obesity Treatment with Significant Body Weight Loss Insilico Medicine has introduced ISM0676, an innovative GIPR antagonist, showing impressive results in body weight reduction and metabolic stability for obesity and related diseases.

Insilico Medicine Unveils ISM0676: A Potential Game-Changer for Obesity Treatment with Significant Body Weight Loss #Cambridge #無し #Insilico_Medicine #GIPR #ISM0676